中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月9日星期三
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2022, Vol. 29 Issue (27): 78-82    
  骨科医学 本期目录 | 过刊浏览 | 高级检索 |
单侧入路双侧减压技术对腰椎退变性椎间盘疾病的治疗效果
陈展鹏    胡奕山    刘伟军    林棉龙    林本丹
广东省汕头市中心医院骨科,广东汕头 515000
Therapeutic effect of bilateral decompression via a unilateral approach technique on lumbar degenerative disc disease
CHEN Zhanpeng    HU Yishan    LIU Weijun    LIN Mianlong    LIN Bendan
Department of Orthopedics, Shantou Central Hospital, Guangdong Province, Shantou 515000, China
全文: PDF (627 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 比较单侧入路双侧减压技术与经椎间孔入路椎体间融合术在治疗老年腰椎退变性椎间盘疾病的临床效果及影像学结果。 方法 回顾性选取2017年1月至2020年4月于汕头市中心医院骨科接受手术治疗的60 例老年腰椎退变性椎间盘疾病患者作为研究对象。根据手术方式的不同,分为单侧入路双侧减压(BDUA)组和经椎间孔椎体间融合(TLIF)组,每组各30 例。比较两组患者手术相关并发症情况、手术时间、术中出血量、引流量、住院天数等围手术期指标,比较两组患者术前、术后的日本骨科协会评分(JOA)、视觉模拟评分法(VAS)和Oswestry功能障碍指数评分(ODI)及术后3 个月融合率。 结果 BUDA 组术中出血量、术后引流量少于TLIF 组,术后3个月VAS 评分低于TLIF 组,差异有统计学意义(P<0.05)。两组患者术前及术后各时间点的JOA 评分、ODI 评分比较,差异无统计学意义(P>0.05)。两组患者术后各时间点融合率及腰椎前凸比较,差异无统计学意义(P>0.05)。两组患者术后6、12 个月融合率和腰椎前凸高于本组术后3 个月,差异有统计学意义(P<0.05)。两组患者术后6 个月与术后12 个月的融合率和腰椎前凸情况组内比较,差异无统计学意义(P>0.05)。结论 单侧入路双侧减压在减少术中出血量、术后引流量,以及减轻术后早期疼痛方面更具有优势。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
陈展鹏
胡奕山
刘伟军
林棉龙
林本丹
关键词 单侧入路双侧减压腰椎退变性椎间盘疾病椎间融合老年患者    
Abstract:Objective To compare the clinical effect and imaging results of bilateral decompression via a unilateral approach technique and transforaminal lumbar interbody fusion in the treatment of senile lumbar degenerative disc disease. Methods A total of 60 patients with senile lumbar degenerative disc disease who underwent surgery in the Department of Orthopaedics, Shantou Central Hospital from January 2017 to April 2020 were retrospectively selected as research objects. According to different surgical methods, they were divided into bilateral decompression via a unilateral approach (BDUA) group and transforaminal lumbar interbody fusion (TLIF) group, with 30 cases in each group. Operation-related complications, the operation time, intraoperative blood loss, drainage volume, hospital stay and other indicators were compared between the two groups. The preoperative and postoperative Japan Orthopedic Association(JOA), visual analogue scale (VAS) and Oswestry disability index (ODI) scores were compared between the two groups.The fusion rate at 3 months after operation was compared between the two groups. Results The intraoperative blood loss, postoperative drainage volume in the BUDA group were less than those in TLIF group, and VAS score at 3 months after operation in the BUDA group was lower than that in the TLIF group, the differences were statistically significant(P<0.05). There were no significant differences in JOA score and ODI score between the two groups before and after operation (P>0.05). There were no significant differences in fusion rate and lumbar lordosis between the two groups after operation (P>0.05). The fusion rate and lumbar lordosis at 6, 12 months after operation in the two groups were higher than those at 3 month after operation, the differences were statistically significant (P<0.05). Conclusion Bilateral decompression via a unilateral approach has more advantages in reducing intraoperative blood loss, postoperative drainage volume and early postoperative pain.
Key wordsBilateral decompression via a unilateral approach    Lumbar degenerative disc disease    Interbody fusion    Elderly patients
    
作者简介: 陈展鹏(1980-),男,广东汕头人,汉族,硕士,副主任医师,研究方向:脊柱外科、创伤骨科。
引用本文:   
陈展鹏; 胡奕山; 刘伟军; 林棉龙; 林本丹. 单侧入路双侧减压技术对腰椎退变性椎间盘疾病的治疗效果[J]. 中国当代医药, 2022, 29(27): 78-82.
CHEN Zhanpeng ;HU Yishan; LIU Weijun; LIN Mianlong; LIN Bendan. Therapeutic effect of bilateral decompression via a unilateral approach technique on lumbar degenerative disc disease. 中国当代医药, 2022, 29(27): 78-82.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2022/V29/I27/78
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载